Discovery of a novel 2,3-dimethylimidazo[1,2-a]pyrazine-6-carboxamide M4 positive allosteric modulator (PAM) chemotype.
Bioorg Med Chem Lett
; 30(3): 126812, 2020 02 01.
Article
in En
| MEDLINE
| ID: mdl-31784320
This Letter details our efforts to discover structurally unique M4 PAMs containing 5,6-heteroaryl ring systems. In an attempt to improve the DMPK profiles of the 2,3-dimethyl-2H-indazole-5-carboxamide and 1-methyl-1H-benzo[d][1,2,3]triazole-6-carboxamide cores, we investigated a plethora of core replacements. This exercise identified a novel 2,3-dimethylimidazo[1,2-a]pyrazine-6-carboxamide core that provided improved M4 PAM activity and CNS penetration.
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Pyrazines
/
Receptor, Muscarinic M4
/
Imidazoles
Language:
En
Journal:
Bioorg Med Chem Lett
Year:
2020
Type:
Article
Affiliation country:
United States